Published in Transplantation on November 15, 2001
Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases. World J Gastroenterol (2013) 1.04
The combined elevation of tumor markers CA 19-9 and CA 125 in liver disease patients is highly specific for severe liver fibrosis. Dig Dis Sci (2006) 0.90
Marked decrease of serum Ca 125 levels after Denver shunt placement in a patient with cirrhosis and refractory ascites. Dig Dis Sci (2006) 0.78
Tumour markers and cirrhosis: the CA-125 who came in from the cold. Can J Gastroenterol (2003) 0.75
Development of a model for training and evaluation of laparoscopic skills. Am J Surg (1998) 5.02
Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med (1993) 4.91
The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies. N Engl J Med (1971) 3.31
Maternal serum AFP secreening. N Engl J Med (1978) 3.17
Experimental mosquito-transmission of Plasmodium knowlesi to man and monkey. Am J Trop Med Hyg (1968) 2.89
Prenatal diagnosis of neural tube defects. III. A reevaluation of the alpha-fetoprotein assay. Obstet Gynecol (1977) 2.24
Factors determining conversion to laparotomy in patients undergoing laparoscopic cholecystectomy. Am J Surg (1994) 2.16
Postcholecystectomy biliary leaks in the laparoscopic era: risk factors, presentation, and management. McGill Gallstone Treatment Group. Gastrointest Endosc (1997) 2.15
The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes. J Clin Invest (1975) 2.13
Results and benefits of a maternal serum alpha-fetoprotein screening program. JAMA (1984) 1.82
Useful predictors of bile duct stones in patients undergoing laparoscopic cholecystectomy. McGill Gallstone Treatment Group. Ann Surg (1994) 1.77
A method for increasing the sensitivity of radial-immunodiffusion assay. Lancet (1970) 1.70
Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst (1995) 1.66
Hepatitis-associated antigen and hepatoma in the U.S. Lancet (1971) 1.64
Cell-mediated immunity in acute and chronic hepatitis. J Clin Invest (1975) 1.63
Alpha-fetoprotein in a patient with gastric carcinoma metastatic to the liver. N Engl J Med (1971) 1.59
A review of the management of post-cholecystectomy biliary leaks during the laparoscopic era. Am J Gastroenterol (1997) 1.56
Use of older donor livers is associated with more extensive ischemic damage on intraoperative biopsies during liver transplantation. Liver Transpl Surg (1999) 1.54
Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis. Lancet (1993) 1.42
The effect of gestational age on the detection rate of Down's syndrome by maternal serum alpha-fetoprotein screening. Am J Obstet Gynecol (1991) 1.39
Liver transplantation: therapeutic option in end-stage liver disease. Tex Med (1988) 1.37
Increased endothelin-1 in bleomycin-induced pulmonary fibrosis and the effect of an endothelin receptor antagonist. Am J Respir Crit Care Med (1997) 1.37
Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein. Cancer (1980) 1.34
Alpha-fetoprotein (AFP) in benign liver disease. Evidence that normal liver regeneration does not induce AFP synthesis. Gastroenterology (1978) 1.32
Experimental hydrostatic pulmonary edema in rabbit lungs. Morphology. Am Rev Respir Dis (1993) 1.31
Natural history of benign esophageal stricture treated by dilatation. Gastroenterology (1983) 1.27
Carcino-foetal human liver ferritins. Nature (1973) 1.27
Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes (1999) 1.26
Human -fetoprotein. Isolation, characterization, and demonstration of microheterogeneity. J Biol Chem (1972) 1.26
Rejection of pig liver xenografts in patients with liver failure: implications for xenotransplantation. Liver Transpl (2001) 1.25
Pulmonary blastoma: case report of a patient with a 7-year remission and review of chemotherapy experience in the world literature. Cancer (1998) 1.25
Effect of lung inflation on pulmonary vascular resistance by arterial and venous occlusion. J Appl Physiol Respir Environ Exerc Physiol (1982) 1.24
Human isoferritins: organ specific iron and apoferritin distribution. Br J Haematol (1975) 1.23
Inflammatory bowel disease associated circulating immune complexes. Gut (1980) 1.19
Abnormality in tissue isoferritin distribution in idiopathic haemochromatosis. Nature (1974) 1.19
Prenatal diagnosis of neural tube defects. I. Problems and pitfalls: analysis of 2495 cases using the alpha-fetoprotein assay. Obstet Gynecol (1976) 1.16
Inflammatory bowel disease: study of cell mediated cytotoxicity for isolated human colonic epithelial cells. Gut (1980) 1.16
Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes. Oncogene (2010) 1.15
Effect of multiparity on human maternal hypersensitivity to foetal antigen. Nature (1973) 1.15
Beta-fetoprotein: identification as normal liver ferritin. Lancet (1973) 1.13
A double-blinded, randomized trial of hydrocortisone in acute hepatic failure. The Acute Hepatic Failure Study Group. Dig Dis Sci (1991) 1.13
Ocular neuroprotection by siRNA targeting caspase-2. Cell Death Dis (2011) 1.12
Predictors of post-ERCP complications in patients with suspected choledocholithiasis. Endoscopy (1998) 1.09
The value of alpha-fetoprotein in the prenatal diagnosis of neural tube defects. J Pediatr (1974) 1.08
Liver transplantation for cholesteryl ester storage disease. J Pediatr Gastroenterol Nutr (1991) 1.08
CD44 involvement in experimental collagen-induced arthritis (CIA). J Autoimmun (1999) 1.08
Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis. Can J Surg (2001) 1.06
An analysis of late deaths after liver transplantation. Transplantation (1996) 1.06
Lysyl oxidase and collagenase in experimental acute and chronic liver injury. Gastroenterology (1982) 1.04
The roles of hyperglycaemia and oxidative stress in the rise and collapse of the natural protective mechanism against vascular endothelial cell dysfunction in diabetes. Arch Physiol Biochem (2007) 1.04
-fetoprotein in human hepatoma: improved detection in serum, and quantitative studies using a new sensitive technique. Gastroenterology (1971) 1.00
Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma. Curr Oncol (2011) 1.00
Central pontine myelinolysis and cyclosporine neurotoxicity following liver transplantation. Transplantation (1996) 0.99
Risks of blind versus open approach to celiotomy for laparoscopic surgery. Surg Laparosc Endosc (1993) 0.99
Helicobacter heilmannii-like spiral bacteria in gastric mucosal biopsies. Prevalence and clinical significance. Arch Pathol Lab Med (1995) 0.99
A prospective trial of D-penicillamine in primary biliary cirrhosis. N Engl J Med (1982) 0.98
Arthritis associated with chronic active hepatitis: complement activation and characterization of circulating immune complexes. Gastroenterology (1975) 0.97
Gamma G subgroups in human fetal, cord, and maternal sera. Clin Immunol Immunopathol (1973) 0.97
Carcinoembryonic antigen: evidence for multiple antigenic determinants and isoantigens. Proc Natl Acad Sci U S A (1975) 0.97
Comparison of neoral dose monitoring with cyclosporine through levels versus 2-hr postdose levels in stable liver transplant patients. Transplantation (1998) 0.95
Quantitative morphology of permeability lung edema in dogs induced by alpha-naphthylthiourea. Lab Invest (1983) 0.95
Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy. Clin Transplant (1998) 0.94
Alpha-fetoprotein levels in normal adults. Am J Med Sci (1992) 0.94
Downregulation of phorbol 12-myristate 13-acetate-induced tumor necrosis factor-alpha and interleukin-1 beta production and gene expression in human monocytic cells by human alpha-fetoprotein. Hepatology (1995) 0.92
Shedding of L-selectin as a mechanism for reduced polymorphonuclear neutrophil exudation in patients with the systemic inflammatory response syndrome. Arch Surg (1996) 0.92
Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy. Br J Cancer (2008) 0.92
Prenatal diagnosis of neural tube defects. II. Analysis of false positive and false negative alpha-fetoprotein results. Obstet Gynecol (1976) 0.92
Integrating routine inquiry about domestic violence into daily practice. Ann Intern Med (1999) 0.92
Clinical benefit of neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients. Transplantation (1999) 0.92
Radioimmunodetection of cancer with radiolabeled antibodies to alpha-fetoprotein. Cancer Res (1980) 0.91
Peak cyclosporine levels (Cmax) correlate with freedom from liver graft rejection: results of a prospective, randomized comparison of neoral and sandimmune for liver transplantation (NOF-8). Transplantation (1999) 0.91
Early detection of pulmonary congestion and edema in dogs by using lung sounds. J Appl Physiol (1985) (1989) 0.90
Alpha-1-fetoprotein. Clin Gastroenterol (1976) 0.90
Transplantation of kidneys from a donor with Neisseria meningitidis infection. Am J Nephrol (1993) 0.89
Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group. Curr Oncol (2010) 0.89
Different distribution of plexiform lesions in primary and secondary pulmonary hypertension. Hum Pathol (1995) 0.89
Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis. Oncogene (2011) 0.89
Mechanisms for the diminished neutrophil exudation to secondary inflammatory sites in infected patients with a systemic inflammatory response (sepsis). Crit Care Med (1999) 0.89
Galactosyltransferase isoenzyme II in the detection of pancreatic cancer: comparison with radiologic, endoscopic, and serologic tests. N Engl J Med (1981) 0.89
Factors affecting the prognosis of primary liver carcinoma. J Clin Oncol (1988) 0.89
Hereditary persistence of alpha-fetoprotein. Gastroenterology (1990) 0.88
Chromosomal structure and localization of the human alpha-fetoprotein gene. Ann N Y Acad Sci (1983) 0.88
Partitioning of pulmonary vascular resistance in dogs by arterial and venous occlusion. J Appl Physiol Respir Environ Exerc Physiol (1982) 0.88
Efficacy of mycophenolate mofetil combined with very low-dose cyclosporine microemulsion in long-term liver-transplant patients with renal dysfunction. Transplantation (2003) 0.88
Differential relaxant responses of pulmonary arteries and veins in lung explants of guinea pigs. J Appl Physiol (1985) (1997) 0.88
Isolation and partial characterization of a specific alpha-fetoprotein receptor on human monocytes. J Clin Invest (1992) 0.88
Secretion by a hybridoma of antibodies against human alpha-fetoprotein. N Engl J Med (1980) 0.88
Complete response of hepatocellular carcinoma with sorafenib and Y radioembolization. Curr Oncol (2010) 0.87
Does interstitial lung edema compress airways and arteries? A morphometric study. J Appl Physiol (1985) (1987) 0.87
Randomised clinical trial: MRCP-first vs. ERCP-first approach in patients with suspected biliary obstruction due to bile duct stones. Aliment Pharmacol Ther (2013) 0.87
Physiology and morphology of pulmonary microvascular injury with shock and reinfusion. J Appl Physiol Respir Environ Exerc Physiol (1981) 0.86
The effect of purified alpha-fetoprotein on in vitro assays of cell-mediated immunity. Cell Immunol (1977) 0.86
Conversion from bladder to enteric drainage after pancreaticoduodenal transplantations. Surgery (1998) 0.86